Journal of Dual Diagnosis最新文献

{"title":"Sex Differences across Retrospective Transitions in Posttraumatic Stress and Substance Use Disorders.","authors":"MacKenzie R Peltier,&nbsp;Walter Roberts,&nbsp;Terril L Verplaetse,&nbsp;Yasmin Zakiniaeiz,&nbsp;Catherine Burke,&nbsp;Kelly E Moore,&nbsp;Sherry A McKee","doi":"10.1080/15504263.2021.2016027","DOIUrl":"https://doi.org/10.1080/15504263.2021.2016027","url":null,"abstract":"<p><p><b>Objectives:</b> Concurrent substance use disorder (SUD) and posttraumatic stress disorder (PTSD) occur at high rates and are typically associated with poor treatment outcomes in both sexes. However, women have a propensity to cope with increased negative affect via substance use in comparison to men; thus, it is important to elucidate the sex-specific bidirectional relationships between SUD and PTSD to improve our understanding of concurrent SUD/PTSD in men and women. <b>Methods:</b> Using data from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-Wave 3; <i>n</i> = 36,309), the present study evaluated the impact of sex on the relationship between past-year SUDs (new, remitted, ongoing), including alcohol and drug use, and retrospective transitions in new <i>vs.</i> absent and ongoing <i>vs.</i> remitted diagnoses of PTSD. Additionally, the impact of sex was explored in models examining past year PTSD (new, remitted, ongoing) and retrospective transitions in new <i>vs.</i> absent and ongoing <i>vs.</i> remitted diagnosis of SUDs. Diagnostic transitions were based on retrospective reporting. <b>Results:</b> Results indicated that new, remitted, and ongoing SUDs increase the likelihood of new PTSD diagnoses (<i>OR</i> range = 2.53-8.11; <i>p</i> < 0.05). Among individuals with ongoing drug use disorders (DUD), there were greater odds of ongoing PTSD (<i>OR</i> = 2.10, <i>p</i> < 0.01). When examining the relationship reciprocally, new, remitted, and ongoing PTSD increased the likelihood of new SUDs (<i>OR</i> range = 2.50-8.22; <i>p</i> < 0.05), and ongoing PTSD increased the likelihood of ongoing SUD and DUD (<i>OR</i> = 1.40, 1.70, respectively; <i>p</i> < 0.05). Sex-specific analyses revealed that the relationship between PTSD and SUDs varies between sexes, particularly among women. For instance, women with new PTSD had higher odds of SUDs, and women with ongoing PTSD were almost 2.5 times more likely to have an ongoing DUD. Women with a new PTSD diagnosis were more likely to be diagnosed with a new SUD (<i>OR</i> = 3.27) and an ongoing DUD (<i>OR</i> = 3.08). <b>Conclusions:</b> Results indicate a bidirectional relationship between PTSD and SUD that is in many instances larger in women. Thus, illustrating potential sex-specific differences in underlying mechanisms implicated in SUD/PTSD, warranting additional research.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"18 1","pages":"11-20"},"PeriodicalIF":2.2,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9086923/pdf/nihms-1798509.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10457320","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Posttraumatic Stress Disorder and Substance Misuse Among Black Emerging Adults: The Influence of Social Support.","authors":"Miranda E Reyes, Joseph S Rossi, Emmanuel D Thomas, Silvi C Goldstein, Nicole H Weiss","doi":"10.1080/15504263.2021.2017221","DOIUrl":"10.1080/15504263.2021.2017221","url":null,"abstract":"<p><p><b>Objective:</b> Black emerging adults are significantly impacted by substance misuse. Posttraumatic stress disorder (PTSD) is associated with heightened substance misuse among Black emerging adults. However, limited research has identified protective factors that may influence the strength of the relation between PTSD and substance misuse in this population. Addressing this important limitation, the present study examined the potential moderating role of perceived social support in the association between PTSD symptoms and substance (i.e., alcohol and drug) misuse. <b>Methods:</b> Participants were 182 trauma-exposed Black emerging adults (<i>M</i> age = 20.50; 71.3% women) who completed self-report measures assessing PTSD symptoms, alcohol and drug misuse, and perceived social support. <b>Results:</b> PTSD symptoms were significantly and positively correlated with both alcohol and drug misuse. Moderation analyses indicated that positive relations between PTSD symptoms and both alcohol and drug misuse were only significant among Black emerging adults with lower (but not higher) levels of perceived social support. <b>Conclusions:</b> These findings suggest the potential utility of addressing social support in the assessment and treatment of substance misuse in trauma-exposed Black emerging adults.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"18 1","pages":"42-51"},"PeriodicalIF":1.5,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9128832/pdf/nihms-1804490.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10806605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Co-Occurring Opioid Use and Depressive Disorders: Patient Characteristics and Co-Occurring Health Conditions.","authors":"Kayla N Tormohlen, Ramin Mojtabai, Anthony Seiwell, Emma E McGinty, Elizabeth A Stuart, Karin E Tobin, Vanessa Troiani","doi":"10.1080/15504263.2021.1979349","DOIUrl":"10.1080/15504263.2021.1979349","url":null,"abstract":"<p><strong>Objective: </strong>Among persons with opioid use disorder (OUD), co-occurring depression is linked to a greater risk of opioid misuse, overdose and suicide. Less is known about characteristics and other comorbid health conditions of persons with co-occurring opioid use and depressive disorders.</p><p><strong>Methods: </strong>This study used electronic health record (EHR) encounters from the Geisinger Health System prior to the fall of 2019. Adult patients were recruited from a medication-based treatment clinic and had an OUD diagnosis (<i>N</i> = 692). Co-occurring depression was defined by a depression diagnosis in the EHR. Multivariable logistic regression was performed to assess differences in characteristics, behavioral health and medical diagnoses, as well as opioid overdose and suicide attempt or ideation between individuals with and without comorbid depression.</p><p><strong>Results: </strong>Forty-seven percent of patients with OUD had a lifetime depression diagnosis. Individuals with co-occurring depression were more likely to be female and have comorbid chronic pain or other medical conditions. Co-occurring depression was associated with an increased likelihood of other mental health and substance use disorders, as well as opioid overdose and/or suicide attempt or ideation.</p><p><strong>Conclusions: </strong>While it is established that co-occurring depression is associated with increased risk of overdose and suicide, this study adds that other health conditions, including chronic pain and common medical conditions, are more prevalent among persons with co-occurring depressive disorders. Results highlight the need to consider these complex health needs when developing treatment plans and services.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 4","pages":"296-303"},"PeriodicalIF":2.2,"publicationDate":"2021-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10294295/pdf/nihms-1765474.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9700942","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Exploring Technology-Based Enhancements to Inpatient and Residential Treatment for Young Adult Women with Co-Occurring Substance Use.","authors":"Dawn E Sugarman,&nbsp;Laurel E Meyer,&nbsp;Meghan E Reilly,&nbsp;Scott L Rauch,&nbsp;Shelly F Greenfield","doi":"10.1080/15504263.2021.1940412","DOIUrl":"https://doi.org/10.1080/15504263.2021.1940412","url":null,"abstract":"<p><strong>Objectives: </strong>Young adults have the highest rates of substance use of any age group. Although men historically have higher rates of substance use disorders (SUDs) than women, research shows this gender gap is narrowing. Young adults with comorbid psychiatric disorders are at increased risk for developing a SUD. Co-occurring psychiatric disorders such as depression, anxiety, eating and post-traumatic stress disorders are more prevalent in women than men with SUDs, yet mental health treatment often does not adequately address substance use in patients receiving care for a comorbid psychiatric disorder. Tailored gender-responsive interventions for women with psychiatric disorders and co-occurring SUD have gained empirical support. Digital interventions tailored to young adult women with co-occurring disorders have the potential to overcome barriers to addressing substance use for young adult women in a psychiatric treatment setting. This study utilized a user-centered design process to better understand how technology could be used to address substance use in young adult women receiving inpatient and residential psychiatric care. <b>Methods:</b> Women (<i>N</i> = 15; age 18-25 years), recruited from five psychiatric treatment programs, engaged in a qualitative interview and completed self-report surveys on technology use and acceptability. Qualitative interviews were coded for salient themes. <b>Results:</b> Results showed that few participants were currently using mental health web-based applications (i.e., \"apps\"), but most participants expressed an interest in using apps as part of their mental health treatment. Participants identified several important topics salient to women their age including substance use and sexual assault, stigma and shame, difficulties abstaining from substance use while maintaining social relationships with peers, and negative emotions as a trigger for use. <b>Conclusions:</b> These data provide preliminary evidence that a digital intervention may be a feasible way to address co-occurring substance use problems in young adult women receiving care in a psychiatric setting.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"236-247"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1940412","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39183865","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Voucher Reinforcement Decreases Psychiatric Symptoms in Young People in Treatment for Drug Use Disorders - A <i>Post Hoc</i> Secondary Analysis of a Randomized Controlled Trial.","authors":"Morten Hesse,&nbsp;Birgitte Thylstrup,&nbsp;Sidsel Karsberg,&nbsp;Michael Mulbjerg Pedersen,&nbsp;Mads Uffe Pedersen","doi":"10.1080/15504263.2021.1942379","DOIUrl":"https://doi.org/10.1080/15504263.2021.1942379","url":null,"abstract":"<p><strong>Objective: </strong>This multicenter, parallel randomized, open study examined the effect of using vouchers and session reminders as an added element to outpatient treatment for drug use disorders in youth. It was hypothesized that being randomly assigned to a contingency management condition would lead to a reduction of psychiatric symptoms, and that this reduction would be mediated through abstinence and treatment completion.</p><p><strong>Methods: </strong>A total of 460 participants aged 15 to 25 years from nine outpatient sites were randomized to one of four treatment conditions (standard treatment alone [STD], i.e., 12 sessions using motivational interviewing and cognitive behavioral therapy, STD plus vouchers for attendance [VOU], STD plus text reminders [REM], or STD plus vouchers and text reminders [REM + VOU]). Participants' symptoms of psychological distress were assessed using the YouthMap 12 instrument at intake, and at 3, 6, and 9 months post-treatment initiation. Interviewers were blinded to interventions.</p><p><strong>Results: </strong>114 participants were randomized to STD, 112 to REM, 113 to VOU, and 121 to VOU + REM. 69 clients were never interviewed for follow-up, leaving 391 for analysis (<i>n</i> = 90, <i>n</i> = 94, <i>n</i> = 99, <i>n</i> = 108). The mean age was 20.5 years (<i>SD</i> = 2.6), 23% were female, and 34% reported having a psychiatric diagnosis. Random effects regression showed that participants randomized to one of the two voucher-based conditions experienced significantly steeper declines in symptoms compared with STD (<i>p</i> < .01). Structural equation modeling results indicated that the effects of contingency management on symptoms were mediated through abstinence, but not sessions attended.</p><p><strong>Conclusions: </strong>Adding contingency management to interventions for drug use disorders can reduce symptoms of psychological and emotional distress among populations of treatment-seeking youth, in part due to indirect effects through abstinence at follow-up. The data is collected from a clinical trial registered as ISRCTN27473213, at https://www.isrctn.com/.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"257-266"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1942379","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39209599","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Impulsive Personality Traits Mediate the Relationship Between Attention-Deficit/Hyperactivity Disorder Symptoms and Psychiatric Comorbidity among Patients with Severe Alcohol Use Disorder.","authors":"Laura Brandt,&nbsp;Frances R Levin,&nbsp;Dominik Kraigher","doi":"10.1080/15504263.2021.1944711","DOIUrl":"https://doi.org/10.1080/15504263.2021.1944711","url":null,"abstract":"<p><strong>Objective: </strong>Attention-deficit/hyperactivity disorder (ADHD) is an established risk factor for developing alcohol use disorder (AUD), and AUD-ADHD comorbidity is associated with additional psychiatric diagnoses. Several lines of evidence support the role of impulsivity as a pathway of these relationships; however, impulsivity is not a unitary construct. Thus, we sought to explore whether separate aspects of impulsivity may explain the relationship between ADHD symptoms and psychiatric comorbidity among inpatients (<i>N</i> = 136) with AUD. <b>Methods:</b> We assessed ADHD symptoms (childhood ADHD [Wender Utah Rating Scale], adult ADHD [Adult ADHD self-report scale]), health-related quality of life (HRQL; EQ-5D-5L), psychiatric comorbidity (Mini International Neuropsychiatric Interview), and impulsive personality traits (Urgency, Premeditation, Perseverance, Sensation seeking [UPPS] scale). <b>Results:</b> 19% of patients screened positive in the retrospective assessment of childhood ADHD, and 17% for adult ADHD. Participants reported moderate levels of problem severity in the HRQL dimensions, and 65% had ≥1 current psychiatric disorders other than AUD and ADHD. Multiple mediation indicated that there was a significant direct effect of childhood ADHD symptoms on psychiatric comorbidity (<i>β</i> = 0.224, 95% CI [0.080, 1.114]), and indirect effects of both reacting impetuously when experiencing negative emotions (negative urgency; <i>β</i> = 0.999, 95% CI [0.043, 0.461]) and the tendency to not finish tasks (lack of perseverance; <i>β</i> = 0.075, 95% CI [0.002, 0.297]). <b>Conclusions:</b> The subcomponents of impulsivity to react rashly when experiencing negative emotions and the tendency to not persist in activities seem to contribute to the relationship between ADHD symptoms (particularly those in childhood) and psychiatric comorbidity among patients with severe AUD.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"193-206"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1944711","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39227131","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Systematic Review of Psychosocial Smoking Cessation Interventions for People with Serious Mental Illness.","authors":"Mark R Hawes,&nbsp;Kimberly B Roth,&nbsp;Leopoldo J Cabassa","doi":"10.1080/15504263.2021.1944712","DOIUrl":"https://doi.org/10.1080/15504263.2021.1944712","url":null,"abstract":"<p><strong>Objective: </strong>Tobacco smoking is a major driver of premature mortality in people with serious mental illness (SMI; e.g., schizophrenia, bipolar disorder). This systematic literature review described randomized control trials of psychosocial smoking cessation interventions for people with SMI, rated their methodological rigor, evaluated the inclusion of racial/ethnic and sexual/gender minorities, and examined smoking cessation outcomes. <b>Methods:</b> Eligible studies included peer-reviewed articles published between 2009 and 2020 that examined psychosocial smoking cessation interventions in people with SMI. We used the Preferred Reporting Items for Systematic Review and Meta-analysis guidelines to conduct our review and the Methodological Quality Rating Scale to evaluate methodological rigor. <b>Results:</b> Eighteen studies were included. Ten were categorized as high methodological rigor given their study characteristics (e.g., longer follow-up) and eight as lower methodological rigor based on their characteristics (e.g., not intent-to-treat). Racial/ethnic and sexual/gender minorities were under-represented in these studies. A range of psychosocial interventions were examined including motivational enhancements, smoking cessation education, cognitive behavioral strategies, and contingency management. Most studies also provided smoking cessation medications (e.g., NRT, bupropion), although provision was not always uniform across treatment conditions. Three studies found the intervention condition achieved significantly higher abstinence from smoking compared to the comparison group. Seven studies found the intervention condition achieved significantly higher reductions in smoking compared to the comparison group. <b>Conclusions:</b> Studies finding significant differences between the intervention and comparison groups shared common evidenced-based components, including providing smoking cessation medications (e.g., NRT, bupropion), motivational enhancement techniques, and cessation education and skills training, but differed in intensity (e.g., number and frequency of sessions), duration, and modality (e.g., group, individual, technology). Methodological limitations and a small number of studies finding significant between-group differences prevent the identification of the most effective psychosocial smoking cessation interventions. Clinical trial designs (e.g., SMART, factorial) that control for the provision of psychosocial medications and allow for the identification of optimal psychosocial treatments are needed. Future studies should also ensure greater inclusion of racial/ethnic and sexual/gender minorities and should be culturally/linguistically adapted to improve treatment engagement and study outcomes.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"216-235"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1944712","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39199764","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Buprenorphine Naloxone and Extended Release Injectable Naltrexone for the Treatment of Opioid Use Disorder Among a Veteran Patient Sample: A Retrospective Chart Review.","authors":"Steven D Shirk,&nbsp;Victoria Ameral,&nbsp;Shane W Kraus,&nbsp;Joseph Houchins,&nbsp;Megan Kelly,&nbsp;Kendra Pugh,&nbsp;Erin Reilly,&nbsp;Nitigna Desai","doi":"10.1080/15504263.2021.1942380","DOIUrl":"https://doi.org/10.1080/15504263.2021.1942380","url":null,"abstract":"<p><strong>Objective: </strong>Previous research has demonstrated the effectiveness of both extended-release injectable naltrexone (XR-NTX) and buprenorphine/naloxone (BUP-NX) in the treatment of opioid use disorder (OUD). However, studies using real-world samples with multiple medical and psychiatric comorbidities are lacking. The study's primary aims were to: (1) compare clinical presentations in an inclusive sample of OUD-diagnosed US military veterans receiving XR-NTX and BUP-NX, and (2) investigate differences in 90-day treatment outcomes between these two groups. <b>Methods:</b> The medical records of 79 patients receiving medications to treat OUD in a VA hospital's addiction outpatient treatment program were reviewed retrospectively. The analysis included all veterans who initiated medication treatment during the study period. Differences between medication groups on co-occurring diagnoses, treatment retention, and related outcomes were examined. <b>Results:</b> The two groups were similar in medical and psychiatric comorbidity, although the BUP-NX group were more likely to have a pain diagnosis. No statistically significant differences in retention or toxicology results were found between the two groups over the 90-day study period. The rate of positive urine screens for the BUP-NX group was 19.2% for opiates and 13.5% for other illicit substances, and 3.7% and 11.1% respectively for the XR- NTX group. <b>Conclusion:</b> There was no evidence that 90-days outcomes differed for veterans based on medication received, and there were more similarities than differences in clinical characteristics. Additional research is needed, including larger sample size and prospective randomized control trial to evaluate VA patients' treatment outcomes receiving BUP-NX or XR-NTX for OUD.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"207-215"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1942380","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39109501","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Treatment Needs and Service Delivery for Patients with Dual Disorders During the COVID-19 Pandemic: Findings From the WADD Survey.","authors":"Yatan Pal Singh Balhara,&nbsp;Nestor Szerman,&nbsp;Swarndeep Singh,&nbsp;Jose Martinez Raga,&nbsp;Caroline Salom,&nbsp;Lola Peris,&nbsp;Ragul Ganesh","doi":"10.1080/15504263.2021.1940413","DOIUrl":"https://doi.org/10.1080/15504263.2021.1940413","url":null,"abstract":"<p><strong>Objective: </strong>The COVID-19 pandemic has posed a great challenge for the existing health systems. The restrictions imposed across countries on the movement of people and the realignment of health care services in response to the pandemic are likely to negatively affect the health status and delivery of mental health services to persons with dual disorders (PWDD). <b>Methods:</b> An online survey was conducted among mental health professionals involved in providing care to PWDD to better understand the problems encountered and identify potential solutions in providing continued treatment for PWDD during the COVID-19 pandemic. <b>Results:</b> The findings confirmed significant disruption in the delivery of treatment services for PWDD during the COVID-19 pandemic. Dissatisfaction with personal protective equipment, inadequate COVID-19 testing services at treatment facility, and lack of guidelines on providing continued treatment services to PWDD by national authorities or professional bodies were identified as the likely reasons for this disruption. <b>Conclusions:</b> These concerns in turn need to be addressed by the policy-makers, hospital management staff, and other stakeholders. Specifically, there should be a focus on developing and disseminating guidelines to assist mental health professionals in setting-up and providing continued treatment services to PWDD via tele-psychiatry and other novel digital strategies.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"248-256"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1940413","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39122294","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mobile Mental Health Apps from the National Center for PTSD: Digital Self-Management Tools for Co-Occurring Disorders.","authors":"Pearl McGee-Vincent,&nbsp;Katherine Juhasz,&nbsp;Andrea L Jamison,&nbsp;Timothy J Avery,&nbsp;Jason E Owen,&nbsp;Beth K Jaworski,&nbsp;Daniel M Blonigen","doi":"10.1080/15504263.2021.1939919","DOIUrl":"https://doi.org/10.1080/15504263.2021.1939919","url":null,"abstract":"<p><p>Mobile mental health apps can help bridge gaps in access to care for those with substance use disorders and dual diagnoses. The authors describe a portfolio of free, publicly available mobile mental health apps developed by the National Center for PTSD. The authors also demonstrate how this suite of primarily non-substance use disorder-specific mobile mental health apps may support the active ingredients of substance use disorder treatment or be used for self-management of substance use disorder and related issues. The potential advantages of these apps, as well as limitations and considerations for future app development, are discussed.</p>","PeriodicalId":46571,"journal":{"name":"Journal of Dual Diagnosis","volume":"17 3","pages":"181-192"},"PeriodicalIF":2.2,"publicationDate":"2021-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1080/15504263.2021.1939919","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39251063","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}